Clinical Trial Update: Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dexamethasone for sodium retention in liver cirrhosis has been terminated. The study was sponsored by Insel Gruppe AG and University …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Liver Cirrhosis | Phase 3 | Status: TERMINATED